Annual SG&A
$18.95 M
+$11.19 M+143.98%
31 December 2023
Summary:
Enliven Therapeutics annual selling, general & administrative expenses is currently $18.95 million, with the most recent change of +$11.19 million (+143.98%) on 31 December 2023. During the last 3 years, it has risen by +$17.88 million (+1658.35%). ELVN annual SG&A is now at all-time high.ELVN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$5.81 M
+$33.00 K+0.57%
30 September 2024
Summary:
Enliven Therapeutics quarterly selling, general & administrative expenses is currently $5.81 million, with the most recent change of +$33.00 thousand (+0.57%) on 30 September 2024. Over the past year, it has increased by +$1.17 million (+25.16%). ELVN quarterly SG&A is now -3.44% below its all-time high of $6.02 million, reached on 31 March 2024.ELVN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$749.06 M
-$85.21 M-12.84%
30 September 2024
Summary:
Enliven Therapeutics TTM selling, general & administrative expenses is currently -$749.06 million, with the most recent change of -$85.21 million (-12.84%) on 30 September 2024. Over the past year, it has dropped by -$765.16 million (-4753.43%). ELVN TTM SG&A is now -1557.14% below its all-time high of $22.43 million, reached on 30 September 2024.ELVN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ELVN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +144.0% | +25.2% | -4753.4% |
| 3 y3 years | +1658.3% | +279.5% | -10000.0% |
| 5 y5 years | - | - | - |
ELVN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1658.3% | -3.4% | +438.5% | -1557.1% | at low |
| 5 y | 5 years | at high | +1658.3% | -3.4% | +438.5% | -1557.1% | at low |
| alltime | all time | at high | +1658.3% | -3.4% | +438.5% | -1557.1% | at low |
Enliven Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $5.81 M(+0.6%) | $22.43 M(+5.5%) |
| June 2024 | - | $5.78 M(-4.0%) | $21.26 M(+4.0%) |
| Mar 2024 | - | $6.02 M(+24.7%) | $20.43 M(+7.8%) |
| Dec 2023 | $18.95 M(+144.0%) | $4.82 M(+3.9%) | $18.95 M(+17.8%) |
| Sept 2023 | - | $4.64 M(-6.2%) | $16.10 M(+10.6%) |
| June 2023 | - | $4.95 M(+9.1%) | $14.56 M(+36.2%) |
| Mar 2023 | - | $4.54 M(+130.8%) | $10.69 M(+37.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | $7.77 M(+81.2%) | $1.97 M(-36.7%) | $7.77 M(+5.9%) |
| Sept 2022 | - | $3.10 M(+187.8%) | $7.33 M(+73.4%) |
| June 2022 | - | $1.08 M(-33.4%) | $4.23 M(+34.3%) |
| Mar 2022 | - | $1.62 M(+5.7%) | $3.15 M(+105.7%) |
| Dec 2021 | $4.29 M(+297.8%) | - | - |
| Dec 2021 | - | $1.53 M | $1.53 M |
| Dec 2020 | $1.08 M | - | - |
FAQ
- What is Enliven Therapeutics annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Enliven Therapeutics?
- What is Enliven Therapeutics annual SG&A year-on-year change?
- What is Enliven Therapeutics quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Enliven Therapeutics?
- What is Enliven Therapeutics quarterly SG&A year-on-year change?
- What is Enliven Therapeutics TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Enliven Therapeutics?
- What is Enliven Therapeutics TTM SG&A year-on-year change?
What is Enliven Therapeutics annual selling, general & administrative expenses?
The current annual SG&A of ELVN is $18.95 M
What is the all time high annual SG&A for Enliven Therapeutics?
Enliven Therapeutics all-time high annual selling, general & administrative expenses is $18.95 M
What is Enliven Therapeutics annual SG&A year-on-year change?
Over the past year, ELVN annual selling, general & administrative expenses has changed by +$11.19 M (+143.98%)
What is Enliven Therapeutics quarterly selling, general & administrative expenses?
The current quarterly SG&A of ELVN is $5.81 M
What is the all time high quarterly SG&A for Enliven Therapeutics?
Enliven Therapeutics all-time high quarterly selling, general & administrative expenses is $6.02 M
What is Enliven Therapeutics quarterly SG&A year-on-year change?
Over the past year, ELVN quarterly selling, general & administrative expenses has changed by +$1.17 M (+25.16%)
What is Enliven Therapeutics TTM selling, general & administrative expenses?
The current TTM SG&A of ELVN is -$749.06 M
What is the all time high TTM SG&A for Enliven Therapeutics?
Enliven Therapeutics all-time high TTM selling, general & administrative expenses is $22.43 M
What is Enliven Therapeutics TTM SG&A year-on-year change?
Over the past year, ELVN TTM selling, general & administrative expenses has changed by -$765.16 M (-4753.43%)